Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05681026 · ClinicalTrials.gov registry record · NA

Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

A NA study of Cancer and Hematopoietic Stem Cell Transplantation, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
3
Study locations

NCT05681026 is a NA study of Cancer and Hematopoietic Stem Cell Transplantation that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 60 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05681026, a NA study of Cancer and Hematopoietic Stem Cell Transplantation, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
3
Study locations

Study Summary

To develop and measure the effects of a culturally sensitive yoga program for inpatients

Interventions

  • BEHAVIORAL Yoga Sessions
  • BEHAVIORAL Questionnaries
  • BEHAVIORAL Interviews

Study Locations (3)

Texas

  • M D Anderson Cancer Center - Houston

Karnataka

  • Swami Vivekananda Yoga Anusandhana Samsthana - Giddenahalli

Other

  • Muhimbili National Hospital - Dar es Salaam

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-08-28
Est. Completion 2028-01-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05681026

The ClinicalTrials.gov registry entry for NCT05681026 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Yoga Sessions is the first listed.

NCT05681026 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Texas, Karnataka, Other.

Frequently Asked Questions

What is clinical trial NCT05681026 about?

NCT05681026 is a clinical study titled "Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States". To develop and measure the effects of a culturally sensitive yoga program for inpatients

What is the current status of trial NCT05681026?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-08-28. Estimated completion is 2028-01-31.

What conditions does trial NCT05681026 study?

This clinical trial studies the following conditions: Cancer, Hematopoietic Stem Cell Transplantation.

What interventions are being tested in trial NCT05681026?

The interventions under investigation include: Yoga Sessions (BEHAVIORAL), Questionnaries (BEHAVIORAL), Interviews (BEHAVIORAL).

Who is sponsoring clinical trial NCT05681026?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05681026 being conducted?

This trial has 3 study locations across Texas, Karnataka. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.